Cat. No. | Product name | CAS No. |
DC60383 | CpUnDMA( PCUnDMA) Featured | 908860-83-3 |
DC60384 |
CTAP
Featured
CTAP is a selective μ opioid receptor antagonist that displays selectivity over δ opioid and somatostatin receptors. CTAP is brain penetrant and active in vivo. |
103429-32-9 |
DC60385 | DLin-S-DMA Featured | 1169768-15-3 |
DC60386 | DLin-2-DMAP Featured | 1169768-10-8 |
DC60387 | Dioley la mi ne-A- succinyl paromomycin DOSP Featured | 959664-11-0 |
DC60388 | C2-DLinDMA Featured | 1192257-55-8 |
DC60389 | GAP-DLRIE Featured | 208040-06-6 |
DC60390 | DLin-K-C4-DMA Featured | 1217306-47-2 |
DC83230 |
TNT-b10
Featured
TNT-b10 is a novel Lipid-like compound suitable for delivery of siRNA and mRNA both in vitro and in vivo TNT-b10 LLNs was more than 10-fold more potent than TNT-a10 LLNs formulated under the same condition. |
|
DC72591 |
OUL232
Featured
OUL232 is a potent inhibitor of mono-ARTs PARP7, PARP10, PARP11, PARP12, PARP14, and PARP15. OUL232 is the most potent PARP10 inhibitor described to date (IC50=7.8 nM), as well as the first PARP12 inhibitor ever reported. |
943119-42-4 |
DC72592 |
Zelasudil
Featured
Zelasudil is a Rho-associated (ROCK) kinase inhibitor. Zelasudil has a ROCK2 binding affinity. |
2365193-22-0 |
DC72598 |
EG-011
Featured
EG-011 is the first-in-class and potent Wiskott-Aldrich syndrome protein (WASP) activator. EG-011 activates the auto-inhibited form of WASP with strong actin polymerization. EG-011 has selective anti-tumor activity in lymphomas. |
2377113-41-0 |
DC72617 |
LAS190792
Featured
LAS190792 (AZD8999) is a potent muscarinic antagonist and β2-adrenoceptor agonist with pIC50 8.9, 8.8, 8.8, 9.2, 8.2, 7.5, 9.1, 5.6 for M1, M2, M3, M4, M5, β1, β2, β3, respectively. LAS190792 can be used as a bronchodilator. |
1347232-69-2 |
DC72649 |
Nimucitinib
Featured
Nimucitinib is a Janus kinase (JAK) inhibitor. |
2740557-24-6 |
DC72651 |
SG-094
Featured
SG094 is a potent TPC2 inhibitor with antiproliferative effects. SG-094 can be used for the research of cancer. |
2922283-37-0 |
DC72663 |
SW222746
Featured
SW222746 (SW 222746) is a potent selective, orally active inhibitor of 15-Prostaglandin dehydrogenase (15-PGDH) with IC50 of 3 nM. |
2241676-74-2 |
DC72666 |
BMS-820132
Featured
BMS-820132 (BMS 820132) is potent, selective, partial glucokinase (GK) activator with AC50 of 29 nM. |
1001419-18-6 |
DC72686 |
SP 600125, negative control
Featured
SP 600125, negative control (SPM1) is an alkyl derivative of pyrazoloanthrone, which can be used as a negative control for SP600125. |
54642-23-8 |
DC72701 |
mono-Pal-MTO
Featured
mono-Pal-MTO is a palm oil-based lipid produced by combining the anticancer drug mitoxantrone (MTO) with palmitoleic acid. When nanoparticles of mono-Pal-MTO and di-Pal-MTO are combined in a molar ratio of 1:1, they show effective siRNA cell delivery and enhance anticancer activity. |
1349197-89-2 |
DC72708 |
di-Pal-MTO
Featured
di-Pal-MTO is a palm oil-based lipid produced by combining the anticancer drug mitoxantrone (MTO) with palmitoleic acid. When nanoparticles of mono-Pal-MTO and di-Pal-MTO are combined in a molar ratio of 1:1, they show effective siRNA cell delivery and enhance anticancer activity. |
1349197-90-5 |
DC72718 |
S19-1035
Featured
S19-1035 is a highly potent and specific aldo-keto reductase 1C3 (AKR1C3) inhibitor. S19-1035 inhibits AKR1C3 with an IC50 value of 3.04 nM. S19-1035 can be used for the research of tumor. |
|
DC72724 |
PTC258
Featured
PTC258 is a specific and orally active splicing modulator of Elongator complex protein 1 gene (ELP1). PTC258 increases the expression of ELP1 in vitro and in vivo. PTC258 is well tolerated in mouse model. |
2476724-74-8 |